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Abstract 
The α1 integrin subunit (SU) belongs to a large 
family of α and β subunits that are noncovalently 
linked to constitute αβ transmembrane units. To date, 
18 α and 8 β subunits are known to form 24 αβ units 
(Takada et al., 2007; Barczyk et al., 2010) which are 
involved in cell-cell and cell-matrix attachment and 
can drive inside-out and outside-in cell signaling 
(Shattil et al., 2010). Integrins are known to 
participate in different cell processes including cell 
shape, differentiation, migration, survival and 
proliferation (Giancotti, 1997; Vachon, 2011; 
Beauséjour et al., 2012). The α1 SU was discovered 
in 1986 as the Very Late Antigen 1 (VLA1) and is 
highly expressed in activated lymphocytes in the 
joints of patients with  
rheumatoid arthritis (Hemler et al., 1986). In 
fibroblasts, α1 is known to activate the RAS/ERK 
proliferative pathway and has a pro-invasive 
function in certain cancers. In megakaryocyte 
differentiation α1 is silenced by DNA methylation 
but not histone modification (Cheli et al., 2007). 
Different transcription factors involved in cancer 
progression can bind to the ITGA1 promoter. 
Integrin α1 transcriptional regulation remains to be 
further defined. 
Identity 
Other names: CD49a, VLA1 
HGNC (Hugo): ITGA1 
Location: 5q11.2 
Figure 1. The human ITGA1 gene is located on chromosome 5 at locus q11.2 and contains 29 exons. Only exons 1 and 2 are 
presented in this diagram. The first intron of ITGA1, which is 69 kb, contains the two exons of the PELO gene. The proximal 
promoter sequence immediately preceeding the initiation transcription site (red line) includes a CpG island (underlined in orange) 
and is predicted to be methylated. This region contains possible regulatory elements for different transcription factors known to 
be involved in various cancers (see text below). 
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Figure 2. αβ heterodimer domain composition. The two subunits have external domains, a transmembrane domain and a small 
cytoplasmic tail. α1 is the largest a subunit, but has the smallest cytoplasmic tail. It contains the I (inserted) domain implicated in 
collagen binding. α1 has no disulfide junctions (no cleavage under reduced conditions) and forms a heterodimer only with the β1 
subunit. When inactive the integrin heterodimer is under a bent conformation. Once activated it becomes open and elongated 
which enhances ligand binding affinity (Arnaout et al., 2005; Shattil et al., 2010). 
DNA/RNA 
Description 
The ITGA1 gene is 165354 bp in length and contains 
29 exons that encode a protein of 1179 aa. 
Transcription 
Transcriptional regulation of the α1 integrin SU: 
transcriptional regulation of ITGA1 was first 
described in smooth muscle cells of the chicken in 
the proximal promoter of ITGA1 containing the 
CArG box for the serum response factor (SRF) 
(Obata et al., 1997). Cheli et al. also reported that 
ITGA1 expression is predominantly regulated by 
DNA methylation and not histone modification in 
human HEK293 cells (Cheli et al., 2007). The 
proximal promoter region of the ITGA1 gene 
contains CpG islands which are selectively and fully 
methylated during differentiation of mononuclear 
cells into the megakaryocyte lineage. This 
mechanism could be responsible for the silencing of 
ITGA1 expression in differentiated intestinal cells. 
Our in silico analysis of the proximal promoter of 
ITGA1 revealed the presence of a number of 
response elements for nuclear factors known to be 
implicated in cancer  
progression such as TCF/LEF and c-Myc 
(unpublished data). Further studies are needed to 
determine a functional relationship between these 
factors and ITGA1 expression. 
Protein 
Note 
Protein access number: P56199. NCBI reference 
sequence: NP_852478.1. 
Expression 
Expression and localisation: the α1 integrin SU 
(figure 2) is highly expressed in various areas of the 
stroma. As reported previously, α1 is present in 
fibroblasts, endothelial cells and smooth muscle 
cells (Gardner, 2014). In the gut, α1 is expressed in 
myofibroblast cells surrounding the crypts of the 
colon and small intestinal mucosa (Boudjadi et al., 
2013). α1 is present in epithelial cells of the 
endometrium, kidney and intestine. In the latter, α1 
is present only in proliferating crypt cells while its 
exclusive partner β1 is constitutively expressed in all 
intestinal cells (Beaulieu, 1992; Boudjadi et al., 
2013). In these cells, α1 is observed in the basolateral 
portion of the cytoplasmic membrane (figure 3). 
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Figure 3. Immunohistochemical images showing examples of α1 integrin subunit expression in the gut. (A) Resection margin 
and (B) corresponding matched colorectal adenocarcinoma specimens. α1 is predominantly expressed in the proliferative cells of 
the crypt (A; red arrows) at the basolateral domain of normal epithelial cells, and also in the endothelial cells (A; black arrow). In 
adenocarcinomas, α1 is highly expressed in tumour epithelial cells (B; red arrows) and reactive stromal cells (B; black arrows). 
Scale bars = 50 μm. 
Function 
α1β1 is the main cell receptor for collagen IV and 
with a lower affinity for collagen I, whereas α2β1 has 
a higher affinity for collagen I (Barczyk et al., 2010). 
α1β1 recognizes the GEFOGER sequence within the 
tertiary structure of collagen IV.  
It is important for cell anchorage to the extracellular 
matrix and is implicated in focal adhesions and cell 
migration.  
The presence of α1β1 in proliferating cells is 
supported by the reported role for α1, via caveolin-1 
and Shc, in the downstream activation of the 
Ras/MEK/ERK proliferative pathway (Giancotti, 
2000).  
In endothelial cells, using a selective mutagenesis 
approach, specific amino acids in the α1 cytoplasmic 
tail are shown to drive various functions and 
pathways. While Lys1147 is important only for 
tubulogenesis, Pro1142 and Leu1145 are required for 
ERK activation and cell proliferation. Lys1146 is 
involved in cell adhesion, migration (activation of 
p38 MAPK) and tubulogenesis (activation of p38 
MAPK and PI3K). Interestingly, substitution of the 
Lys1151 positively charged amino acid at the COOH-
terminus of the α1 tail results in a complete loss of 
the above functions. This positively charged amino 
acid could be required for α1 orientation relative to 
the β1 tail, compromising binding to signal 
molecules (Abair et al., 2008). 
Mutations 
Note 
No mutation known for human ITGA1 gene. 
Implicated in 
Lung cancer 
Note 
In mouse models, the α1β1 integrin mediates cell 
invasion through the regulation of stromelysin-1 
expression (Lochter et al., 1999) and, together with 
the Kras oncogenic factor, potentiates tumour 
growth and cell motility (Macias-Perez et al., 2008). 
Colorectal cancer 
Note 
Integrin α1β1 is up-regulated in 65% of colon 
adenocarcinomas compared to matched margins. 
Expression is found to be higher in epithelial cells 
and the surrounding reactive cells (Boudjadi et al., 
2013).  
Also, α1β1 is present in the early stages of colorectal 
cancer which could constitute a useful early 
diagnostic marker. 
Hepatocellular carcinoma 
Note 
In a fibrotic microenvironment similar to that of 
hepatocellular carcinoma, α1β1 has been reported to 
be able to enhance cell invasion through the fibrotic 
matrix (Yang et al., 2003). 
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